Literature DB >> 29860675

Association of Toll-like receptor 3 and Toll-like receptor 9 single-nucleotide polymorphisms with hepatitis C virus persistence among Egyptians.

Shaimaa Hamdy1, Ahmed M Osman2, Zainab A Zakaria1,3, Iman Galal1, Maha Sobhy1, Mohamed Hashem1,4, Walaa R Allam1,5, Mohamed Abdel-Samiee6, Eman Rewisha6, Imam Waked6, Sayed F Abdelwahab7,8,9.   

Abstract

Toll-like receptors (TLRs) give the innate immune system a considerable specificity for a large range of pathogens. TLR3 detects dsRNA of viruses while TLR9 recognizes bacterial and viral unmethylated CpG motifs. This study examined whether there is a potential association between single-nucleotide polymorphisms (SNPs) in the TLR3.rs3775290 (c.1377C/T), TLR9.rs5743836 (-1237T→C) and TLR9.rs352140 (G2848A) genes and HCV infection among Egyptian patients and healthcare workers (HCWs). We enrolled 546 subjects (409 HCWs and 137 patients) divided into four groups: group 1 included 265 seronegative, aviremic subjects; group 2 included 25 seronegative, viremic subjects; group 3 included 87 subjects with spontaneously resolved HCV infection; and group 4 included 169 chronic HCV patients. All subjects were genotyped for TLR3.rs3775290, TLR9.rs5743836 and TLR9.rs352140 SNPs by polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) analysis. TLR3.rs3775290 "CC" genotype was associated with chronic HCV infection, where there was a significantly greater frequency of this genotype among chronic patients when compared to subjects with spontaneously resolved infection (63.9% vs. 51.9%; p = 0.033; OR = 1.639 and 95% CI = 0.94-2.84). However, this SNP did not correlate with the HCV RNA load among the chronic subjects (p > 0.05). There was no significant difference in TLR9.rs5743836 and TLR9.rs352140 genotype distribution between groups (p > 0.05). Lack of association between the three SNPs was found, as the three SNPs are located on two different chromosomes. In conclusion, the TLR3.rs3775290 "CC" genotype was associated with HCV chronicity, while the TLR9 gene may not play a major role in HCV infection.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29860675     DOI: 10.1007/s00705-018-3893-8

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  5 in total

Review 1.  Pattern Recognition Receptors: Significance of Expression in the Liver.

Authors:  Jan Żeromski; Agata Kierepa; Bartosz Brzezicha; Arleta Kowala-Piaskowska; Iwona Mozer-Lisewska
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2020-09-17       Impact factor: 4.291

2.  The association between micro-RNA gene polymorphisms and the development of hepatocellular carcinoma in Egyptian patients.

Authors:  Maha M Allam; Karema A Diab; Fatma O Khalil; Fatma A Khalaf; Mohamed Abdel-Samiee; Nashwa Sheble; Mohamed A Eljaky; Essam Zayed; Warda Othman; Mervat Abd-Elkreem; Eman Abdelsameea
Journal:  Arch Med Sci       Date:  2021-03-18       Impact factor: 3.318

3.  Association of toll-like receptors single nucleotide polymorphisms with HBV and HCV infection: research status.

Authors:  Yaxin Xu; Wentao Xue; Hongwei Gao; Jiabo Cui; Lingzhi Zhao; Chongge You
Journal:  PeerJ       Date:  2022-04-19       Impact factor: 3.061

4.  Association of the polymorphism of the Toll-like receptor (TLR)-3 and TLR-9 genes with hepatitis C virus-specific cell-mediated immunity outcomes among Egyptian health-care workers.

Authors:  S F Abdelwahab; S Hamdy; A M Osman; Z A Zakaria; I Galal; M Sobhy; M Hashem; W R Allam; M Abdel-Samiee; E Rewisha; I Waked
Journal:  Clin Exp Immunol       Date:  2020-10-02       Impact factor: 4.330

5.  Role of resistin, IL-6 and NH2-terminal portion proBNP in the pathogenesis of cardiac disease in type 2 diabetes mellitus.

Authors:  Samar Ebrahim Ghanem; Mohamed Abdel-Samiee; Mohamed Hamdy Torky; Ahmed Gaafar; Somia Mokabel Mohamed; Ghada Mohamed Mohamed Salah Eldin; Samah Mohammed Awad; Karema A Diab; Dalia M ELsabaawy; Sania Ali Yehia; Hany Abdelbary Abdelaziz Elbasyouni; Amr Aly Elshormilisy
Journal:  BMJ Open Diabetes Res Care       Date:  2020-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.